It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
And Now For Something… Completely The Same: The Agreement On The UPC Whatever Happened To ‘Classical’ European Patents?
-
Fordham Conference Day 1
-
The Role of Scientific Advisers in the English Patents Court
-
Father Christmas: beware of risks of patent infringement
-
Cloned Sheep And Other Patent Eligibility Issues In The U.S.
-
Does obtaining marketing authorization and price to market a medicament constitute sufficient indicia of "imminent" infringement?
-
Cross-Examination of French Judges (Interview Part I: National Introspection)
-
When to lift an injunction before the case on the merits is completed…
-
European complainants in declaratory non-infringement actions: If you do not have locus standi under your national laws, go to England
-
Quetiapine patent invalidated in Denmark – also…